CBX1 and neoplasm: Furthermore, we identified significantly better tumor shrinkage within the CBX1‐high group among the patients receiving anti‐PD‐1 therapy plus chemotherapy, while no differences were identified between the CBX1‐high and CBX1‐low groups for the matched patients receiving chemotherapy alone (Figure 7B).